Key result
Pathogenic HTAAD variants are linked to ~13-fold higher odds of thoracic aortic aneurysm and dissection.
Why the study?
Are pathogenic or likely pathogenic variants in HTAAD genes and increased polygenic risk scores associated with an increased risk of thoracic aortic aneurysm and dissection?
Observational
Yes
Are pathogenic or likely pathogenic variants in HTAAD genes and increased polygenic risk scores associated with an increased risk of thoracic aortic aneurysm and dissection?
Answers are grounded in this paper and cite their sources.
Both rare pathogenic variants in HTAAD genes and higher polygenic risk scores independently and additively increase the risk of thoracic aortic aneurysm and dissection.
BACKGROUND AND AIMS: Thoracic aortic aneurysm and dissection (TAAD) can have catastrophic health consequences. Eleven genes have strong or definitive evidence for causing heritable TAAD (HTAAD). The aim of this work was to determine the prevalence and effect of rare, pathogenic or likely pathogenic (P/LP) variants in HTAAD genes on the association of TAAD diagnoses, and whether increased polygenic risk is associated with an additive effect on monogenic risk. METHODS: This genetic association study used data from Penn Medicine Biobank (PMBB) and MyCode Biobank. P/LP HTAAD gene variants were adjudicated according to American College of Medical Genetics and Genomics standards. A polygenic risk score (PRS) was derived from a genome-wide association study of aortic diameter to assess polygenic TAAD risk. The main outcome of interest, TAAD, was identified using an algorithmic review of electronic health records. Regression analyses were performed to determine the monogenic and polygenic effects on TAAD risk. RESULTS: Across the two cohorts, .2%-.3% of participants carried a P/LP HTAAD gene variant. Individuals carrying P/LP HTAAD gene variants had a significantly higher odds of TAAD compared to non-carriers [odds ratio (OR) 13.5, 95% confidence interval (CI) 5.3-34.6, P < .001] with variable effects when stratified by gene. A one standard deviation increase in the PRS was associated with an OR for TAAD of 1.43 (95% CI 1.39-1.47, P < .001). TAAD prevalence was higher among individuals carrying a P/LP HTAAD gene variant in the highest PRS quintile compared to carriers in the lowest PRS quintile (relative risk 2.32, 95% CI 1.29-4.17, P < .01), suggesting that polygenic risk may be an important additive factor in rare variant TAAD risk. CONCLUSIONS: P/LP HTAAD gene variants confer a substantial population-level increased risk of TAAD. Polygenic risk represents an additive factor for rare variant TAAD risk, suggesting that integrating monogenic and polygenic risks has the potential to enhance patient risk stratification and treatment.
No takes yet. Share an insight, caveat, or question.
DePaolo et al. (2026) conducted an observational in Thoracic aortic aneurysm and dissection (TAAD). Pathogenic or likely pathogenic (P/LP) variants in HTAAD genes vs. Non-carriers was evaluated on Thoracic aortic aneurysm and dissection (TAAD) (OR 13.5, 95% CI 5.3-34.6, p=< .001). Carrying pathogenic or likely pathogenic HTAAD gene variants was associated with higher odds of thoracic aortic aneurysm and dissection compared to non-carriers.
Synapse has enriched 10 related papers. Consider them for comparative context: